VANCOUVER, BC and HOUSTON, TX / ACCESSWIRE / May 16, 2024 / Bio Conscious Technologies Inc., a global leader at the intersection of Artificial Intelligence (AI) and Health Technology today announced a ...
Platform now available to pharmaceutical research partners; powers collaborations totaling over $200 million SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery ...
GUANGHAN, CHINA / ACCESSWIRE / August 20, 2021 / On April 27, Zhang Ge, Board Chairman and President of Sichuan Deebio Pharmaceutical Co., Ltd. (hereinafter referred to as Deebio), participated in the ...
Ajinomoto Bio-Pharma Services is taking full control of an API manufacturing facility in India as the CDMO continues to bulk up in a market that favors companies that can do it all. Ajinomoto ...
API-192 is a first-in-class off-the-shelf allogeneic CAR-NKT cell therapy that expresses dual CARs targeting CD19 and CD20 and armored with soluble IL-15 for improved expansion and persistence API-192 ...
Sharon Bio-Medicine today said it has received approval from the US health regulator for its API plant at Taloja in Maharashtra. The company, however, said it cannot start supplying to the US market ...
Endobits Automated Remote Patient Management Platform Will Now Deploy Its Industry-Leading AI-Powered Software to Securely Integrate Dexcom CGM Data VANCOUVER, BC and HOUSTON, TX / ACCESSWIRE / May 16 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback